Barclays PLC Meridian Bioscience Inc Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$31.15 - $33.39 $632,936 - $678,451
20,319 Added 67.79%
50,293 $1.67 Million
Q3 2022

Nov 03, 2022
BUY
$30.9 - $33.55 $507,810 - $551,360
16,434 Added 121.37%
29,974 $945,000
Q2 2022

Aug 12, 2022
SELL
$23.75 - $31.69 $793,036 - $1.06 Million
-33,391 Reduced 71.15%
13,540 $412,000
Q1 2022

May 16, 2022
SELL
$19.97 - $26.94 $343,503 - $463,394
-17,201 Reduced 26.82%
46,931 $1.22 Million
Q4 2021

Feb 14, 2022
BUY
$17.46 - $21.61 $376,175 - $465,587
21,545 Added 50.59%
64,132 $1.31 Million
Q3 2021

Nov 09, 2021
BUY
$17.35 - $22.5 $170,602 - $221,242
9,833 Added 30.02%
42,587 $818,000
Q2 2021

Aug 13, 2021
SELL
$18.01 - $28.32 $507,575 - $798,142
-28,183 Reduced 46.25%
32,754 $727,000
Q1 2021

May 13, 2021
BUY
$19.76 - $29.89 $27,071 - $40,949
1,370 Added 2.3%
60,937 $1.6 Million
Q4 2020

Feb 11, 2021
SELL
$15.73 - $21.66 $86,436 - $119,021
-5,495 Reduced 8.45%
59,567 $1.11 Million
Q3 2020

Nov 12, 2020
BUY
$13.54 - $26.41 $296,363 - $578,062
21,888 Added 50.7%
65,062 $1.1 Million
Q2 2020

Aug 12, 2020
SELL
$7.84 - $23.29 $77,568 - $230,431
-9,894 Reduced 18.64%
43,174 $1.01 Million
Q1 2020

May 13, 2020
SELL
$5.57 - $11.5 $111,227 - $229,643
-19,969 Reduced 27.34%
53,068 $444,000
Q4 2019

Feb 10, 2020
BUY
$7.9 - $10.14 $130,571 - $167,593
16,528 Added 29.25%
73,037 $713,000
Q3 2019

Nov 14, 2019
SELL
$9.17 - $12.01 $42,466 - $55,618
-4,631 Reduced 7.57%
56,509 $537,000
Q2 2019

Aug 14, 2019
BUY
$10.88 - $17.6 $298,133 - $482,275
27,402 Added 81.22%
61,140 $726,000
Q1 2019

May 15, 2019
BUY
$15.51 - $17.61 $275,178 - $312,436
17,742 Added 110.92%
33,738 $594,000
Q4 2018

Feb 14, 2019
SELL
$14.52 - $19.72 $506,210 - $687,498
-34,863 Reduced 68.55%
15,996 $278,000
Q3 2018

Nov 14, 2018
BUY
$14.85 - $16.35 $326,299 - $359,258
21,973 Added 76.07%
50,859 $757,000
Q2 2018

Aug 14, 2018
SELL
$13.8 - $16.8 $22,162 - $26,980
-1,606 Reduced 5.27%
28,886 $460,000
Q1 2018

May 15, 2018
BUY
$13.8 - $16.2 $110,455 - $129,664
8,004 Added 35.59%
30,492 $432,000
Q4 2017

Feb 14, 2018
BUY
$13.55 - $15.8 $228,615 - $266,577
16,872 Added 300.43%
22,488 $315,000
Q3 2017

Nov 14, 2017
BUY
$13.45 - $14.35 $75,535 - $80,589
5,616
5,616 $81,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email